Blog Post | Topical Cannabinoids: Hype or Help?
Thursday, August 10, 2017
“One study that investigated human use of a topical cannabinoid for pain reduction with facial post-herpetic neuralgia found that 5 out of 8 subjects reported a mean pain reduction of 87.8% with no adverse events reported.”
Read Full Blog on Dermcast.tv
|
|
Email to a Friend